ESR1 and breast cancer: In addition, metastatic ovarian lesions in breast cancer sometimes mimic the clinical and histological features of primary ovarian cancer and even lose the characteristic oestrogen receptor (ER) and progesterone receptor (PR) expression levels [12,13].